Pretreatment neutrophil-to-lymphocyte ratio predicts treatment efficacy and prognosis of cytotoxic anticancer drugs, molecular targeted drugs, and immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Masashi Ishihara, Ryosuke Ochiai, Terunobu Haruyama, Takahiko Sakamoto, Shigeru Tanzawa, Takeshi Honda, Shuji Ota, Yasuko Ichikawa, Tsuyoshi Ishida, Kiyotaka Watanabe, Nobuhiko Seki